Healthcare -
Biotechnology - NASDAQ - US
$ 9.705
0.674 %
$ 2.9 B
Market Cap
-28.54
P/E
FOLD - PRE-TAX INCOME
Pre-tax Income FOLD - Amicus Therapeutics, Inc.
-150 M
LAST VALUE
21.17%
2 YEAR CAGR
15.53%
5 YEAR CAGR
-9.04%
10 YEAR CAGR